MedPath

Clinical study of tuina based on the mechanical characteristics of key lumbar muscle groups combined with celecoxib in the treatment of lumbar disc herniatio

Phase 1
Recruiting
Conditions
umbar Disc Herniation
Registration Number
ITMCTR2100004296
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who meet the diagnostic criteria of lumbar disc herniation;
2. Patients aged 20-65 years old (inclusive), regardless of gender;
3. Subjects with unilateral L4 / 5 or L5 / S1 disc herniation by lumbar magnetic resonance or CT examination;
4. Patients with a history of more than 2 weeks and less than 6 months;
5. Patients with VAS score >= 3;
6. Patients who understand and agree to participate in this study and sign informed consent.

Exclusion Criteria

1. Patients with other major lumbar diseases, such as tumor, tuberculosis, etc.;
2. Patients with acute lumbar injury and pain caused by trauma or operation;
3. Patients with cardiovascular, lung, kidney, hematopoietic system and other major diseases;
4. Mental patients;
5. Patients with osteoporosis;
6. Pregnant or lactating women;
7. Patients with contraindications to oral celecoxib;
8. Subjects with contraindications of MRI.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Visual Analog Scale (VAS);Improved Oswestry dysfunction index;
Secondary Outcome Measures
NameTimeMethod
Muscle surface EMG signal; 3D motion capture assessment;Dosage of celecoxib;Assessment of muscle tissue status (compliance);
Âİ Copyright 2025. All Rights Reserved by MedPath